Mira Murati
Technik-/Wissenschafts-/F&E-Leiter bei OpenAI OpCo, LLC
Profil
Mira Murati currently works at Unlearn.AI, Inc., as Director from 2023 and OpenAI OpCo, LLC, as Chief Technology Officer from 2023.
Aktive Positionen von Mira Murati
| Unternehmen | Position | Beginn |
|---|---|---|
Unlearn.AI, Inc.
 Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 21.03.2023 |
OpenAI OpCo, LLC
 OpenAI OpCo, LLC Packaged SoftwareTechnology Services OpenAI, Inc. operates as a capped-profit company that allows to increase investments in compute and talent while including checks and balances. Its investors and employees can get a capped return which allows to raise investment capital and attract employees with startup-like equity. The company was founded on March 11, 2019 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
OpenAI OpCo, LLC
OpenAI OpCo, LLC Packaged SoftwareTechnology Services OpenAI, Inc. operates as a capped-profit company that allows to increase investments in compute and talent while including checks and balances. Its investors and employees can get a capped return which allows to raise investment capital and attract employees with startup-like equity. The company was founded on March 11, 2019 and is headquartered in San Francisco, CA. | Technology Services |
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | Technology Services |
